The promotion and progression of prostate cancer (PCa) are associated with androgen receptor (AR) signalling. AR functions are modulated by a variety of co-factors amongst which we identified the nucleophosmin (NPM/ B23), a member of the histone chaperone family. Here, we show that NPM is overexpressed in PCa compared to normal adjacent tissues. AR and NPM interact in vitro and in vivo, and NPM is critical for androgen-dependent transcriptional activation in LNCaP cells as an anti-NPM siRNA downregulates transcription of a transfected androgen response element (ARE)-containing reporter promoter as well as expression of the endogenous androgen responsive prostate-specific antigen (PSA) gene. By investigating the effect of NPM on AR, we have also observed that NPM enhances AR binding to an ARE in vitro in electrophoretic gel mobility-shift assay experiments. Chromatin immunoprecipitation studies further demonstrated that both AR and NPM associate with AREs of the PSA gene in vivo. Altogether, our data suggest that the molecular histone chaperone NPM could regulate AR functions by promoting assembly of ARcontaining regulatory complexes and that high levels of NPM might alter AR functions in PCa.
Introduction
The development and progression of prostate cancer (PCa) is mainly promoted by a deregulation in androgen signalling (Hsing et al., 2000) . The effects of androgens are mediated by the androgen receptor (AR) and when PCa progresses to metastatic carcinomas, patients are treated in order to decrease the circulating level of androgens and to inhibit the transcriptional activities of AR. Nevertheless, the disease often escapes from hormonal treatment and gains an androgen-independent growth phase where paradoxically, the AR signalling pathway can still remain active and promote tumour growth through molecular mechanisms that have yet to be clarified. Upon binding to DNA regions containing the androgen response element (ARE), the AR either up-or down-regulates gene expression in response to androgens. This ability of the AR to affect transcription relies on its interaction with co-activators and corepressors depending on whether they enhance or inhibit AR transcriptional activities (Heinlein and Chang, 2002; Wang et al., 2005) . Type I co-regulators function primarily by facilitating AR binding to DNA, remodelling chromatin and/or recruiting general transcription factors associated with the RNA polymerase II holocomplex (Lemon and Tjian, 2000) , whereas type II co-regulators enable the proper folding of AR, control its trafficking and/or influence its ligand-binding activity (Hu et al., 2004) . Interestingly, molecular chaperones were also shown to interact physically and functionally with steroid receptors and thus to contribute to hormone binding. Recent studies revealed supplementary functions of molecular chaperones through which they may promote association of steroid receptors with hormone response element along with co-activators within the promoter region of target genes (reviewed in Morimoto, 2002) .
Molecular chaperones are thought to function by dual mechanism by targeting chromatin remodelling through histone modifications and by acting as transcriptional intermediaries between the activation domains of steroid receptors and general transcription factors. Our laboratory has recently identified the molecular chaperone nucleophosmin (NPM/B23/NO38/numatrin) as a novel AR-interacting protein (Le´otoing et al., unpublished data) . NPM is a nuclear protein that shuttles between the nucleolus and the cytoplasm (Szebeni et al., 1995) . Firstly reported to play a role in ribosome assembly (Savkur and Olson, 1998) , it has also been shown to bind to histones, to mediate nucleosome formation and to relax chromatin (Okuwaki et al., 2001) . Furthermore, NPM is known to interact with the tumour suppressor proteins p53, Rb and p19 ARF (Takemura et al., 1999; Colombo et al., 2002; Bertwistle et al., 2004) and to bind to several cellular and viral proteins as well as transcription factors including YY1, NFkB and AP2a (Inouye and Seto, 1994; Dhar et al., 2004; Liu et al., 2007) . NPM appears to be much more abundant in tumour cells and in proliferating cells compared to normal cells and is proposed to play a crucial role in transcriptional regulation (Bertwistle et al., 2004) .
In this communication, we show that NPM is highly co-expressed with the AR in secretory epithelial cells of localized PCas. Using co-immunoprecipitation, we clearly demonstrated that NPM and AR interact in vivo in PCa lymph node carcinoma of the prostate (LNCaP) cells and knocking-down of NPM by RNA interference markedly reduced transcription from the androgenresponsive prostate-specific antigen (PSA) gene. We also showed that NPM strongly binds to the DNA-binding domain (DBD)/hinge domain of AR in vitro and that the NPM protein facilitates AR binding to its consensus ARE. Chromatin immunoprecipitation studies indicate that NPM is delocalized from the genomic AREs in a hormone-dependent manner in vivo while the AR is targeted to the same response elements. This suggests that NPM might participate in the assembly of transcriptional regulatory complexes by making way for AR and its co-activators to be recruited to the nucleus and to interact with the AREs. Taken together, our findings suggest that NPM might function to enhance the action of the AR and play an important co-regulatory role in PCa.
Results

NPM is overexpressed in PCa tissue
To evaluate NPM expression in PCa, several tumours and adjacent normal tissues from prostate were analysed by western blotting. Micro-biopsies from six human patients undergoing radical prostatectomy revealed that NPM is overexpressed in tumours, the mean value of NPM quantification being fivefold higher in the tumour tissue compared with the normal adjacent tissue (Figure 1a) . Of great interest, this observation is found in conjunction with an eightfold overaccumulation for AR in neoplastic prostate tissue sections (Figure 1a , right graph). No such change was observed for b-3-tubulin, which is preferentially expressed in the epithelial compartment (Ranganathan et al., 1997) indicating thus that the increased levels of both NPM and AR in tumour samples are not due to a higher epithelial content. To determine which specific types of prostate cells express NPM, immunohistochemistry using an anti-NPM antibody was carried out on 50 paraffin embedded sections of clinically characterized human PCas treated or not with hormonal therapy. NPM was found predominantly confined to the nucleus of both prostate stromal and epithelial cells ( Figure 1b) and for all the patients studied, the intensity of the staining only varied in epithelial tumour cells where it was found higher than in the surrounding normal Figure 1 Nucleophosmin (NPM) is overexpressed in prostate cancer (PCa) biopsies. (a) Androgen receptor (AR) and NPM are overexpressed in PCa tissues. Micro-biopsies from normal (N, all the tissue is non-tumoral) and adjacent tumoral (T, all the tissue is tumoral) tissues were realized on six different patients after radical prostatectomy and then AR and NPM levels were analysed using western blotting. Histograms show the band quantification reported to the actin level (*Po0.01). The b-3-tubulin is used as a marker of the epithelial compartment. (b) NPM immunostaining in normal and adjacent tumour tissues. Paraffin-embedded sections of prostate tumours were immunostained with NPM. Full scale bars correspond to 400 mm and hatched scale bars to 100 mm.
NPM/B23 enhances AR-dependent transcription in CaP L Léotoing et al epithelium (Figure 1b) . Indeed, all of the adenocarcinoma examined exhibited strong and extensive staining for NPM with no evident differences between high compared to low Gleason patterns. Moreover, we also found that prostate carcinoma with a high proportion of NPM overexpressing cells also present a higher level of AR immunostaining in the nuclear compartment of the secretory epithelial cells (Supplementary Figure 1) .
AR and NPM interact in PCa cells in vivo and in vitro Our finding that NPM and AR are co-expressed at high levels in the nuclear compartment of the human prostate gland tumours suggests that NPM could interact and regulate the transcriptional activity of AR in PCa. To determine whether NPM associates with AR in vivo, whole cell lysates (CL) prepared from LNCaP PCa cells were immunoprecipitated with normal rabbit IgG or an anti-NPM polyclonal antibody. As shown in Figure 2a , the AR protein was detected only when the anti-NPM antibody was used, in the presence or in the absence of androgens. As expected, an anti-AR antibody also co-immunoprecipitates NPM (Figure 2b ). This finding was corroborated using PC3 cells transfected for AR (Supplementary Figure 2) . These data indicate that both AR and NPM can reside within a same protein complex.
To test whether AR and NPM interact physically and to further localize their binding domains, we generated glutathione S-transferase (GST)-AR and GST-NPM fusion proteins. Using in vitro-synthesized (IVS) hemagglutinin (HA)-tagged NPM, we found that the DBD/ The equal loading of GST fusion proteins was controlled with S-Ponceau.
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Hinge domain of AR was strongly associated with NPM while the binding capacities for NPM of both N-and Cterminal domains of AR are lower in the same conditions ( Figure 2c ). Interestingly, the three domains of the AR bind equally well to NPM in GST pull-down assays when total CL prepared from PC3 cells expressing the HA-tagged NPM protein were used. The latter result suggests that other proteins are probably involved in this AR-NPM interaction. In addition, Figure 2d showed that AR binds to full-length NPM as well as to both the oligomerization-domain (OligoD) and the heterodimerization-domain/nuclear-binding domain (HeteroD/NBD). Deletion of these two regions abolished the interaction of NPM with AR indicating that the acidic/nuclear localisation signal (Ac/NLS) domain of NPM is not sufficient for binding to AR. Altogether, these data indicate that AR and NPM interact in vitro through multiple domains and that other proteins seem to modulate this interaction in vivo.
NPM is important for androgen-dependent gene expression in PCa cells NPM has already been shown to modulate transcription following protein-protein interactions with several transcription factors (Colombo et al., 2002; Maiguel et al., 2004; Weng and Yung, 2005) . Using RNA interference, we therefore investigated the role of NPM in regulating transcription of the endogenous androgenresponsive PSA gene. NPM siRNA was transfected in LNCaP cells cultured with or without dihydrotestosterone (DHT) and PSA mRNA levels were measured via reverse transcription real-time PCR following normalization to b-actin expression. NPM knockdown resulted in a 30% decrease in the PSA mRNA level and in a 50% decrease in the PSA protein after a 48 h exposure to DHT when compared to a control siRNA ( Figure 3a ). Similar to the findings in Figure 3a , loss of NPM reduced DHT-stimulated transcription of the PSAluciferase reporter gene by about fivefold (Figure 3b ). Although NPM was described as a key factor in rRNA processing (Savkur and Olson, 1998) , the decreased DHT-dependent transcription we observed is unlikely the result of a general effect on transcription since expression of a CMV-driven luciferase reporter gene was unaffected by the reduction of NPM (Supplementary Figure 3 ). To investigate the role of NPM in the function of other nuclear hormone receptors, we performed similar studies with the class II nuclear receptor LXR. In contrast with AR, NPM knockdown had no effect on the transcriptional activity of LXR using an AKR1B7-luciferase reporter gene (Volle et al., 2004) indicating that NPM cannot influence the activity of all members of the nuclear receptor gene family. To elucidate the mechanisms by which NPM controls AR transcription activity, we further tested the ability of Gal4-DBD chimera proteins containing either the N-or C-terminal domains of AR to activate a reporter gene driven by an UAS containing promoter. Notably, the Gal4-DBD/AR N-term increased the activity of the UAS promoter in control cells (Figure 3c , left panel) and transfection of NPM siRNA did not alter this activity. Moreover, NPM siRNA transfection did not modify the UAS-luciferase activity of Gal4-DBD/AR C-term in response to DHT either ( Figure 3c , middle panel). We next investigated whether NPM could regulate AR DNA binding as NPM interacts mainly with the DNAbinding and hinge domains of AR. To do so, we analysed the effect of a NPM knockdown on the ability of the AR-DBD/Hinge chimera protein fused to the VP16 transactivation domain to activate a PSA-luciferase reporter gene. As shown in Figure 3c (right panel), the transfection of the AR-DBD/hinge/VP16 resulted in an increase of the PSA-luciferase reporter gene in control cells. Of interest, transfection of NPM siRNA significantly reduced luciferase activity in these conditions, suggesting that NPM could control AR transcriptional activity by enhancing its DNA-binding capacity rather than its transactivation functions.
NPM protein increases AR-binding activity for AREs in vitro
To test our hypothesis that NPM could modulate androgen-dependent transcription through enhanced AR DNA binding, we performed electrophoretic gel mobility-shift assays (EMSA) using the distal ARE of the AKR1B7 promoter (Fabre et al., 1994) . Our data showed that AR-DBD/Hinge fused to GST was capable to bind to an ARE while either GST or GST-fused to NPM did not (Figure 4a ). Interestingly, addition of NPM increases in a dose-dependent manner the AR-DBD/Hinge-binding affinity by approximately three-to fourfold. NPM did not seem to be retained as a stable component of the complexes as the addition of NPM did not result in a shift and the complexes are not efficiently super-shifted by an anti-NPM antibody ( Figure 4b ). Similar results were obtained when purified His 6 -tagged NPM proteins were used (Supplementary Figure 4) . To supply further evidences that NPM enhances AR binding to its response element, we tested the capacity of the Ac/NLS domain of NPM, which is unable to interact with AR in vitro (Figure 2c ), to influence DNA binding of the AR. As observed, the full length NPM increased the AR DNA-binding activity by about twofold (Figure 4d , lanes 5, 6) but, neither the GST alone (lanes 2, 3), and more importantly nor the Ac/NLS domain of NPM fused to GST (lanes 7, 8) were able to improve AR binding. Altogether, these results clearly demonstrate the ability of NPM to mediate a stronger binding affinity of the AR for its cognate sites. This could represent a way by which NPM controls AR activity.
NPM and AR interact with AREs of the PSA promoter in vivo In real-time PCR analyses, we showed that the DHTinduced accumulation of PSA mRNA is significantly reduced in PCa LNCaP cells when NPM is knockeddown. These cells were therefore used to determine the DHT-induced occupancy of the AREs at the promoterproximal region (ARE I and ARE II) and at the NPM/B23 enhances AR-dependent transcription in CaP L Léotoing et al enhancer region (ARE III) of the PSA gene. In the absence of DHT, low levels of AR were bound to chromatin. After 2 h of hormone treatment, we observed an increased occupancy of AR at the enhancer region containing ARE III and to a lesser degree at both AREs of the proximal promoter region ( Figure 5b) ; the extent of these increases was, respectively, 15-and 8-fold greater than the average changes measured at the two control segments that lack functional AREs, namely, the 3 0 -untranslated region of the PSA gene (3 0 NT) and the b-actin promoter as already reported (Kim et al., 2003) . Interestingly, NPM was associated with all three AREs in the absence of hormone with a higher level of recruitment on the ARE I located within the proximal promoter region (Figure 5c ). This agrees with the recent reports on NPM DNA-binding affinity and its histone chaperone activity (Hingorani et al., 2000; Okuwaki et al., 2001) . Unexpectedly, the signal representing the level of NPM at the response elements was reduced specifically by more than twofold after hormone treatment as already reported for another molecular chaperone namely Bag-1L (Shatkina et al., 2003) . As proposed by Shatkina et al. for Bag-1L, NPM might act by making a way for AR and other co-activators that are recruited to the nucleus by the hormone to interact. Figure 3 Nucleophosmin regulates AR transcriptional activity. (a) NPM siRNA downregulates androgens-induced prostate-specific antigen (PSA) levels. Lymph node carcinoma of the prostate (LNCaP) cells were transfected with 100 nM control siRNA or specific NPM siRNA. Twelve hours after transfection, cells were incubated for additional 36 h with or without 10 nM dihydrotestosterone (DHT). mRNAs for NPM and b-actin were analysed using quantitative PCR. The histograms show the densitometric analysis of PSA mRNA levels normalized using b-actin mRNA levels (*Po0.01). Cell lysates were analysed by western blotting with indicated antibodies. Actin was used as a loading control. The histograms show the densitometric analysis of PSA protein expression levels (*Po0.01). (b) Nucleophosmin regulates AR transcriptional activities. LNCaP cells were co-transfected with 100 nM control siRNA or specific NPM siRNA and with a PSA-Luc reporter plasmid (left panel). After 12 h, the cells were treated for 36 h with or without 10 nM DHT. NPM knockdown effect on androgen-regulated promoter activity was evaluated by measuring the luciferase activity (*Po0.01). As a control of nuclear receptor specificity (right panel), LNCaP cells were co-transfected with 100 nM control siRNA or specific NPM siRNA, with LXRa, RXR expression vectors and the AKR1B7/LXRE-Luc reporter plasmid, then after 12 h, treated for 36 h with or without 1 mM T091317 and 9-cis-retinoic acid. The data shown are representative of at least three independent triplicate experiments. (c) NPM regulates AR DNA-binding activity. LNCaP cells were transfected with Gal4-DBD fused to AR amino (Nterm., left panel) or carboxyl (C-term., middle panel) terminal domains constructions and a reporter driven by an UAS containing promoter, or with a AR DBD/hinge/VP16 and a PSA-Luc reporter (right panel), in the presence of 100 nM control siRNA or 100 nM specific NPM siRNA. After 12 h, cells were treated for 36 h with or without 10 nM DHT. NPM knockdown effect on androgenregulated promoter activity was evaluated by measuring the luciferase activity (*Po0.01). The data shown are representative of at least three independent triplicate experiments.
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Discussion
The assembly of macromolecular complexes represents a key step in the regulation of gene expression and different combinations of molecular chaperones were shown to govern steroid receptor functions in response to hormone. Recent studies have shown that molecular chaperones may modulate the transactivation functions of nuclear receptors at the level of their interaction with DNA, in addition to their role in providing the ligandbinding pocket with the correct conformation (Morimoto, 2002) . In this communication, we show that the molecular chaperone NPM is overexpressed together with AR in the localized human PCas biopsies we examined, that both proteins interact in vitro and in vivo, and that NPM modulates the activity of the AR by regulating its binding to AREs. Our data indicate that NPM is a potential factor involved in tumour progression through AR signalling pathway. Mapping of AR-interacting domains with NPM revealed that the interaction is mainly supported by the DBD/hinge region of the receptor. Concomitant with this observation, analyses of AR DNA binding by EMSA show that NPM elicits a several fold increase in AR binding to its response element. Moreover, our results also demonstrate that the Ac/NLS fragment of NPM, which does not interact with AR, has no effect on the receptor binding to DNA, further indicating that the NPM-AR interaction could be important for androgenenhanced transcriptional activation. Nevertheless, it is interesting to notice that the presence of NPM did not affect the mobility of the complexes and that the use of an anti-NPM antibody did not result in the supershift of the retarded protein-DNA complex as would have been expected if NPM was present in the complex. Similar findings have already been reported for the highmobility group box 1 (HMGB1) protein which facilitates the DNA binding of several steroid receptors, including AR, without being present in the DNA/ receptor complex in EMSA experiments (Boonyaratanakornkit et al., 1998; Verrijdt et al., 2002) . In a general hit-and-run mechanism, the authors have suggested that the HMGB1 protein might be a transient and unstable component of the steroid receptor/steroid response element complex that does not take part in the interactions within the final transcription activation complex. This hit-and-run mechanism is consistent with our chromatin immunoprecipitation studies where occupancy of the AREs on an androgen-responsive gene by NPM is disrupted in vivo by hormone whereas AR is selectively recruited to its response elements. We thus hypothesize that NPM might act to recruit AR to its response elements in a suitable conformation to activate androgen-dependent transcription along with a variety of co-regulatory proteins.
Regulation of chromatin transcription is a complex phenomenon that involves the sequential remodelling of chromatin followed by the recruitment of the general transcription machinery to the promoter. Ligandinduced AR activity is enhanced by p300 and mutation of the AR acetylated motif abrogates p300 and DHTstimulated activity (Fu et al., 2000) . Knowing that the NPM/B23 enhances AR-dependent transcription in CaP L Léotoing et al co-regulatory protein p300 is recruited in vivo on both the PSA promoter and enhancer in response to DHT (Kang et al., 2004 ), acetylation appears to be an essential step in ligand-dependant activation of AR. Interestingly, p300 was recently shown to play a significant role in the acetylation of NPM that resulted in its association with histones, in the nucleosome disruption and in the subsequent activation of transcription (Swaminathan et al., 2005) . We can assume that p300 together with NPM might participate in the control of androgen-dependent transcription although the existence of a ternary complex of AR, NPM and p300 remains to be established.
It is noteworthy that NPM is not observed to influence the activity of class II nuclear receptor LXR, while it specifically influences the activities of the steroid hormone receptors AR, PR, ER and GR (our unpublished data). These two classes of receptors differ both in the structure of their DNA-binding domain and in the mechanism of DNA binding (Melvin and Edwards, 1999) . Indeed, class II nuclear receptors are described bound to even in the absence of cognate ligand, while steroid receptors need hormone for nuclear translocation and subsequent DNA binding. The latter might involve steps that depend upon histone chaperones like NPM. Further studies will be required to analyse and link the effect of NPM on the DNA-binding capacity of the nuclear hormone receptor family and the enhancement of the receptors transcription activity.
In the light of our results, it therefore appears that the NPM-AR interaction may be linked to the regulation of gene expression by androgens during prostate carcinogenesis. Although there are controversial reports on NPM level in PCa (Bocker et al., 1995; Subong et al., 1999) , our work brings clear data assessing NPM and AR overexpression in PCa compared to normal adjacent tissues. Immunohistochemistry studies demonstrated that a strong and extensive staining for NPM was found in neoplastic prostate tissues while it is present at lower levels in the basal and luminal epithelial cells. Interestingly, AR is also higher expressed in the same sections of adenocarcinomas. Considering the effect of NPM on Lymph node carcinoma of the prostate (LNCaP) cells were cultured in phenol red-free RPMI medium supplemented with 5% charcoal-stripped fetal bovine serum for 72 h, then treated with or without 10 nM dihydrotestosterone (DHT) for two additional hours. After cross-linking and sonication, AR (b) and NPM (c) were immunoprecipitated and their occupancy on the different PSA promoter AREs were analysed by amplifying the corresponding regions using quantitative real-time PCR (left panels). The 3 0 NT and a fragment on the actin promoter were used to check the specificity of AR and NPM bindings. For each antibody, the corresponding IgG was used as a negative control of immunoprecipitation (right panels). (*Po0.01, **Po0.05). Data are representative of at least two independent IP and three independent PCR amplifications.
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L Léotoing et al AR signalling demonstrated in our study, we propose that this deregulation could be a reason of aberrant activity of AR in such cells, taking part in prostate tumorigenesis. NPM exhibits the highest affinity for the AR-DBD/hinge region. The hinge region contains the NLS, and a short sequence that modulates the AR transactivation abilities by controlling the intramolecular N/C folding and the binding of co-activators of the p160 family (Haelens et al., 2007) . NPM might then drive AR into the nucleus to ensure the receptor in a transcriptional competent state (Szebeni et al., 1995) . Since this histone chaperone has such a nucleuscytoplasm shuttling property that could regulate AR trafficking and cellular sublocalization, and that it could control AR transcription capacities, this alternative mechanism should be explored too. In summary, our findings indicate that NPM is overexpressed in PCas and that this histone chaperone is important for androgen-dependent gene expression in PCa cells. We show that NPM facilitates AR DNA binding to its response elements and we suggest that the inter-relationship between AR and NPM and their effect on androgen-responsive genes may play a crucial role in PCa.
Materials and methods
Plasmid constructs and western blot antibodies are available as Supplementary Materials.
Cell culture, transient transfections and luciferase assays PC3 cells were cultured in Dulbecco's modified Eagles medium (DMEM) supplemented with 10% heat-inactivated fetal bovine serum (FBS) and gentamycin (50 mg ml
À1
). LNCaP cells were maintained in phenol red-free RPMI 1640 medium containing FBS and gentamycin (50 mg ml À1 ). 3 Â 10 5 LNCaP cells per well were plated in six-well plates, and the next day transient transfections were performed in OPTI-MEM using Lipofectin (Invitrogen, Cergy-Pontoise, France). For depletion of NPM, we used a combination of two siRNA duplexes: 5 0 -CCACAGAAAAAAGUAAAACTT-3 0 and 5 0 -UGAUGA AAAUGAGCACCAGTT-3 0 . GFP siRNA duplex (5 0 -ACTA CCAGCAGAACACCCCTT-3 0 ) was used as a control for the siRNA reactions. RNA duplexes (final concentration 100 pmol) were transfected into LNCaP cells (3 Â 10 5 cells per well) in six-well plates using Metafecten (Biontex Laboratories, Martinariea/Planegg, Germany) or with Lipofectin when siRNA duplexes were co-transfected with other plasmids. After 12 h, the medium was replaced, and cells were treated with androgens, 9-cis-retinoic acid and T091317, or ethanol vehicle for 36 h. Cells were lysed and the luciferase activity was measured with the assay system from Yelen.
Subjects
For western-blotting studies, prostate tissue samples were obtained from six patients with a mean age of 64.1 years (range 53-73) who underwent radical prostatectomy from January 2002 to June 2005 at the Centre Hospitalier Lyon Sud. Immediately after prostate removal (delay o10 min) small pieces of tissues (at least six samples of tissues of 0.5-1 cc) were gross dissected by the pathologist, in the left, the right peripheral zone and in the transitional area. All fragments were snap-frozen and stored in liquid nitrogen until analysis. To determine whether the tissue was malignant or nontumoural and to confirm the Gleason score, histological analysis of a frozen section was performed for each sample by the same pathologist before any extraction. The fragments fully constituted of tumoural glands were selected and named 'tumoural tissues'; samples that do not contain tumoural tissue were selected and named 'non-tumoural tissues'. Patients were included in the study when tumoural and non-tumoural tissue was found in the same biopsy. For immunohistochemical studies, the paraffin-embedded tissue sections were obtained from 50 cases of radical prostatectomy or endo-urethral resection. The fragments were either fixed in Bouin's liquid or neutral formol. All the cases were reviewed by a pathologist to confirm the malignancy and the Gleason Score. Tumours were classified as high grade when the Gleason score was 7 or higher and as low grade when the score was 6 or lower. The ethics committee of the medical faculty and the state medical board agreed to these investigations and an informed consent was obtained from all patients.
Western blot analysis
Human tissues were homogenized in TRIzol reagent (Invitrogen) and extracted according to the manufacturer's instructions. Whole-cell proteins were obtained by resuspending cells in high salt buffer (0.42 M NaCl, 20 mM Hepes (pH 8.0), 1.5 mM MgCl 2 , 0.2 mM EDTA, 25% glycerol, 0.1% NP-40, 1 mM PMSF, 1 mg ml À1 apoprotinin, 1 mg ml À1 leupeptin)) as described elsewhere (Le´otoing et al., 2007) . Proteins were analysed by western blotting using the indicated antibodies.
Immunohistochemistry
Paraffin blocks of fixed prostate tissues were sectioned at 5 mm. The sections were mounted on Superfrost plus glass slides, deparaffinized, hydrated and heated 20 min at 93-98 1C in citric buffer (10 mM, pH 6.0). Then, the Envision kit (Dako, Trappes, France) was used according to the manufacturer's recommendations. The sections were then incubated overnight at 4 1C with a rabbit polyclonal NPM antibody (1:50) (3542, Cell signalling, Ozymo, Saint Quentin en Yvelines, France). Sections were counterstained with Mayer's hematoxylin, mounted in Faramount and evaluated by two independent pathologists.
GST pull-down experiments
Full-length NPM cDNA, the oligoD domain (1-120), the Ac/ NLS domain and the HeD/NBD domain were subcloned into pGEX4T1 (Pharmacia Biotech, Orsay, France) in frame with the GST. The expression vectors containing the N-terminus, the DBD/hinge, the C-terminus part of AR fused with GST and the GST pull-down assay methodology were described elsewhere (Baron et al., 2004) . The bound complexes were analysed by western blot and fusion proteins were stained with S-Ponceau.
Immunoprecipitation
LNCaP cells were harvested, washed in ice-cold PBS buffer and lysed in IP buffer (150 mM NaCl, 0.1% Triton, 50 mM Tris-HCl (pH 8.0), 1 mM EDTA). Cell lysates were precleared with Protein-A/G Sepharose beads and then incubated with rabbit IgG or specific anti-AR (PG21) or anti-NPM (C19) antibodies conjugated with pre-equilibrated Protein-A/G Sepharose beads rotating 3 h at 4 1C. The beads were collected, washed with IP buffer and proteins were eluted by boiling in SDS-sample buffer, resolved on polyacrylamide gels, and transferred to nitrocellulose membranes for immunoblotting.
Preparation of RNA and real-time quantitative PCR Total cellular RNA was extracted using TRIzol reagent and reverse transcribed with random hexamers. Each sample was amplified using QuantiTect SYBR Green PCR Kit (Qiagen, Courtaboeuf, France) in a Roche thermocycler. For PSA, the primers were 5 0 -GCATCAGGAACAAAAGCGTGA-3 0 and 5 0 -CCTGAGGAATCGATTCTTCAG-3 0 and for b-actin: 5 0 -C GTGGGCCGCCCTAGGCACCA-3 0 and 5 0 -TTGGCCTTA GGGTTCAGGGGGG-3 0 .
Gel-shift assay electrophoretic mobility shift assay (EMSA in text) Electrophoretic mobility-shift assays were performed as described (Darne et al., 1997) . Radiolabelled probe was incubated with recombinant GST-tagged AR-DBD/hinge in binding buffer for 30 min on ice in the presence of increasing amount of GST or GST-NPM recombinants proteins. The motif used is the mouse AKR1B7 ARE (5 0 -TTAAAAGA ACATGCTGCTCTAACCG-3 0 ). A 100-fold excess of cold double stranded probe was used for the competition experiments and an oligonucleotide containing the AKR1B7 LXRa responsive element (5 0 -TTGAAAGGTCATCCAAGATGA ACTGG-3 0 ) was used as a nonspecific competitor. For the supershift assays, a polyclonal rabbit anti-NPM antibody was added and rabbit IgG were used as a negative control.
Chromatin immunoprecipitation assay
LNCaP cells (25 Â 10 6 ) were cultured in medium supplemented with 5% charcoal stripped FBS for 72 h. Cells were treated with DHT for 2 h and proceeded as described (Kim et al., 2003) . The precleared supernatant was immunoprecipitated by incubating at 4 1C overnight with anti-AR (PG21), anti-NPM (C19) or purified IgG, and immune complexes were obtained by incubating with protein A-Sepharose at 4 1C for 1 h. After purification, DNA samples were quantified by RT-PCR using the following primers: ARE I forward 5 0 -GGTGCATCC AGGGTGATCTA-3 0 and reverse 5 0 -AAACCTTCATTCCCC AGGAC-3 0 ; ARE II forward 5 0 -AGGGATCAGGGAGTCT CACA-3 0 and reverse 5 0 -GCTAGCACTTGCTGTTCTGC-3 0 ; ARE III forward 5 0 -GACAACTTGCAAACCTGCTC-3 0 and reverse 5 0 -GATCCAGGCTTGCTTACTGT-3 0 . NT 3 0 -forward 5 0 -TGGCCTAGAGCCTCAGATGT-3 0 and reverse 5 0 -TT CCAAGTACAGGGCTCACC-3 0 and b-actin forward 5 0 -TC CTCCTCTTCCTCAATCTCG-3 0 and reverse 5 0 -AAGGCAAC TTTCGGAACGG-3 0 . One percent of soluble chromatin was processed in parallel without immunoprecipitation, and values obtained from this DNA were used to calculate immunoprecipitated DNA as percentage of input.
Densitometry and statistical analysis Autoradiograms were scanned and densities were quantified using Quantity-One software (Bio-Rad). Values are expressed as mean ± s.d. Where appropriate, a one-way analysis of variance (ANOVA) followed by a Fisher's t-test was conducted to analyse for differences between treatment. Statistical significance was determine at *Po0.01 and **Po0.05.
